Medicamen Biotech Ltd Quarterly Results

Gross Sales

45.14

44.74

43.05

47.32

46.5

Excise Duty

0

0

0

0

0

Net Sales

45.14

44.74

43.05

47.32

46.5

Other Operating Income

0

0

0

0

0

Other Income

0.14

0.29

0.59

0.57

0.83

Total Income

45.28

45.03

43.63

47.89

47.33

Total Expenditure

38.44

39.43

39.6

41.57

41.61

PBIDT

6.85

5.6

4.03

6.32

5.72

Interest

0.76

1.04

0.71

1.89

0.65

PBDT

6.09

4.56

3.33

4.43

5.08

Depreciation

2.21

2.61

1.77

1.77

1.8

Minority Interest Before NP

0

0

0

0

0

Tax

1.03

1.05

0.84

0.79

0.99

Deferred Tax

-0.07

0

-0.08

-0.18

0.26

Reported Profit After Tax

2.92

0.9

0.8

2.04

2.03

Minority Interest After NP

-0.55

-0.55

-0.55

-0.09

-0.37

Net Profit after Minority Interest

3.47

1.46

1.35

2.13

2.4

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

3.47

1.46

1.35

2.13

2.4

EPS (Unit Curr.)

2.3

0.71

0.63

1.61

1.6

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

12.71

12.71

12.71

12.71

12.65

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

15.17

12.51

9.36

13.35

12.3

PBDTM(%)

13.49

10.19

7.73

9.36

10.92

PATM(%)

6.46

2.01

1.85

4.31

4.36